Following MHRA inspection in March 2025, this overview outlines how enzyme indicators are incorporated into routine QA decision-making within a regulatory-inspected aseptic manufacturing environment.
The aseptic manufacture of systemic anti-cancer therapy (SACT) requires highly controlled environments and reliable decontamination to protect patient safety and maintain regulatory compliance. Hydrogen peroxide (H₂O₂) isolators are increasingly used in aseptic pharmacy settings to support high-assurance decontamination while enabling scalable batch production.
The Clatterbridge Cancer Centre implemented H₂O₂ isolators within its aseptic pharmacy service to support on-site batch manufacture of chemotherapy treatments, following a structured validation programme and regulatory inspection.
Protak Scientific supported the validation programme behind this initiative, working alongside the Clatterbridge team from cycle development through to inspection-ready documentation.
The initiative forms part of a broader focus on resilience, throughput, and confidence in batch release within healthcare manufacturing environments. Particular attention was given to how decontamination assurance is integrated into routine QA workflows to minimise delays and operational bottlenecks.
A statement from The Clatterbridge Cancer Centre is provided separately and linked below.
Read about the advantages and benefits of using our Enzyme Indicators for your H₂O₂ bio-decontamination validation processes.
Biological Indicators vs Enzyme Indicators at a glance.
Presentations, white papers, webinars, shared articles, project summaries and product analysis.
Luminox House,
48 Holmethorpe Avenue
Redhill, Surrey
RH1 2NL
United Kingdom
Tel: +44 (0) 1737 924 900
Fax: +44 (0) 1737 924 901